Literature DB >> 11841920

Iron regulation of hepatic macrophage TNFalpha expression.

Hidekazu Tsukamoto1.   

Abstract

Sustained TNFalpha induction is central to the pathogenesis of chronic liver disease including alcoholic liver disease (ALD). However, molecular understanding of this abnormality at the cellular level remains elusive. Redox regulation of NF-kappaB is critical in the transcriptional control of TNFalpha expression. Evidence supports that increased iron storage in hepatic macrophages (HM) is causally associated with accentuated and sustained NF-kappaB activation in these cells in ALD. Treatment of cultured HM with a lipophilic iron chelator (deferiprone) abrogates LPS-induced NF-kappaB activation. HM from an animal model of ALD have increased nonheme iron content accompanied by increased generation of EPR-detected radicals, NF-kappaB activation, and TNFalpha induction, all of which are normalized by ex vivo treatment of the cells with deferiprone. A moderate increase in the nonheme iron content in HM by erythrophagocytosis, promotes subsequent LPS-stimulated NF-kappaB activation in a hemeoxygenase-dependent manner. Recent evidence also suggests a role of intracellular low molecular weight iron in the early signal transduction for LPS-mediated NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841920     DOI: 10.1016/s0891-5849(01)00772-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

1.  Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Authors:  Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

Review 2.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  MFehi adipose tissue macrophages compensate for tissue iron perturbations in mice.

Authors:  Merla J Hubler; Keith M Erikson; Arion J Kennedy; Alyssa H Hasty
Journal:  Am J Physiol Cell Physiol       Date:  2018-05-16       Impact factor: 4.249

Review 4.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

5.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

6.  Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production.

Authors:  L Harhaji; O Vuckovic; D Miljkovic; S Stosic-Grujicic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 7.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

8.  Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.

Authors:  Akira Uchiyama; Jae-Sung Kim; Kazuyoshi Kon; Hartmut Jaeschke; Kenichi Ikejima; Sumio Watanabe; John J Lemasters
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases.

Authors:  Guang-Fu Xu; Xin-Yue Wang; Gui-Ling Ge; Peng-Tao Li; Xu Jia; De-Lu Tian; Liang-Duo Jiang; Jin-Xiang Yang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis.

Authors:  Wang Liao; Wanbao Yang; Zheng Shen; Weiqi Ai; Quan Pan; Yuxiang Sun; Shaodong Guo
Journal:  Diabetes       Date:  2021-01-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.